Antiretroviral therapy in Indian setting: when and what to start with, when and what to switch to?
Kumarasamy, N.; Patel, A.; Pujari, S.
Indian Journal of Medical Research 134(6): 787-800
2011
ISSN/ISBN: 0019-5340 PMID: 22310814 Document Number: 561015
With the rapid scale-up of antiretroviral therapy, there is a dramatic decline in HIV related morbidity and mortality in both developed and developing countries. Several new safe antiretroviral, and newer class of drugs and monitoring assays are developed recently. As a result the treatment guideline for the management of HIV disease continue to change. This review focuses on evolving science on Indian policy--antiretroviral therapy initiation, which drugs to start with, when to change the initial regimen and what to change.
Document emailed within 1 workday
Related Documents
Ruzicka, D.J.; Kuroishi, N.; Oshima, N.; Sakuma, R.; Naito, T. 2019: Switch rates, time-to-switch, and switch patterns of antiretroviral therapy in people living with human immunodeficiency virus in Japan, in a hospital-claim database Bmc Infectious Diseases 19(1): 505Boyle, B.A. 2001: Issues in antiretroviral therapy: when to start? Aids Reader 11(2): 66-70
Naidoo, K.; Baxter, C.; Abdool Karim, S.S. 2013: When to start antiretroviral therapy during tuberculosis treatment? Current Opinion in Infectious Diseases 26(1): 35-42
Walensky, R.P.; Wolf, L.L.; Wood, R.; Fofana, M.O.; Freedberg, K.A.; Martinson, N.A.; Paltiel, A.D.; Anglaret, X.; Weinstein, M.C.; Losina, E.; Messou, E.èn.; Seyler, C.; Touré, S.; Yazdanpanah, Y.; Kumarasamy, N.; Ganesh, J.; Ganesh, A.K.; Gray, G.; McIntyre, J.; Mohapi, L.; Cotich, K.; Goldie, S.; Horsburgh, C.R.; Kimmel, A.; Lipsitch, M.; McCormick, A.; Rydzak, C.; Seage, G.R.; Zhang, H.; Hsu, H.E.; Bassett, I.V.; Bender, M.A.; Chung, S.; Ciaranello, A.; Linas, B.P.; Lu, Z.; Morris, B.; Saxena, A.; Sloan, C.; Uhler, L.; Wang, B. 2009: When to start antiretroviral therapy in resource-limited settings Annals of Internal Medicine 151(3): 157-166
Musisi, S.; Wagner, G.J.; Ghosh-Dastidar, B.; Nakasujja, N.; Dickens, A.; Okello, E. 2014: Depression and sexual risk behaviour among clients about to start HIV antiretroviral therapy in Uganda International Journal of Std and Aids 25(2): 130-137
Rodger, A.J.; Sabin, C.A. 2016: How have guidelines on when to start antiretroviral therapy affected survival of people living with HIV infection? Current Opinion in HIV and Aids 11(5): 487-491
Vanobberghen, F.M.; Kilama, B.; Wringe, A.; Ramadhani, A.; Zaba, B.; Mmbando, D.; Todd, J. 2015: Immunological failure of first-line and switch to second-line antiretroviral therapy among HIV-infected persons in Tanzania: analysis of routinely collected national data Tropical Medicine and International Health: Tm and Ih 20(7): 880-892
Kalyesubula, R.; Kagimu, M.; Opio, K.C.; Kiguba, R.; Semitala, C.F.; Schlech, W.F.; Katabira, E.T. 2011: Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting African Health Sciences 11(1): 16-23
Pathipvanich, P.; Ariyoshi, K.; Rojanawiwat, A.; Wongchoosie, S.; Yingseree, P.; Yoshiike, K.; Warachit, P.; Sawanpanyalert, P. 2003: Survival benefit from non-highly active antiretroviral therapy in a resource-constrained setting Journal of Acquired Immune Deficiency Syndromes 32(2): 157-160
Rupali, P.; Mannam, S.; Bella, A.; John, L.; Rajkumar, S.; Clarence, P.; Pulimood, S.A.; Samuel, P.; Karthik, R.; Abraham, O.C.; Mathai, D. 2012: Risk factors for mortality in a south Indian population on generic antiretroviral therapy Journal of the Association of Physicians of India 60: 11-14
Tassie, J-Michel.; Marquardt, T.; Damisoni, H.; Odhiambo, O.Didakus.; Mulemba, M.; Szumilin, E.; Legros, D. 2004: Indirect markers to initiate highly active antiretroviral therapy in a rural African setting Aids 18(8): 1226-1228
Deshwal, R.; Arora, S. 2019: High Prevalence of Vitamin D Deficiency in HIV Infected on Antiretroviral Therapy in a Cohort of Indian Patients Journal of the Association of Physicians of India 67(3): 42-45
Agu, K.A.; Oqua, D.; Agada, P.; Ohiaeri, S.I.; Adesina, A.; Abdulkareem, M.H.; King, R.C.; Wutoh, A.K. 2014: Assessment of satisfaction with pharmaceutical services in patients receiving antiretroviral therapy in outpatient HIV treatment setting International Journal of Clinical Pharmacy 36(3): 636-647
Gargano, J.W.; Laserson, K.; Muttai, H.; Odhiambo, F.; Orimba, V.; Adamu-Zeh, M.; Williamson, J.; Sewe, M.; Nyabiage, L.; Owuor, K.; Broz, D.; Marston, B.; Ackers, M. 2012: The adult population impact of HIV care and antiretroviral therapy in a resource poor setting, 2003-2008 Aids 26(12): 1545-1554
Haberer, J.E.; Kiwanuka, J.; Nansera, D.; Wilson, I.B.; Bangsberg, D.R. 2010: Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting Aids and Behavior 14(6): 1294-1301
Okomo, U.; Togun, T.; Oko, F.; Peterson, K.; Townend, J.; Peterson, I.; Jaye, A. 2012: Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa Bmc Pediatrics 12: 95
Hurley, E.; Coutsoudis, A.; Giddy, J.; Knight, S.E.; Loots, E.; Esterhuizen, T.M. 2011: Weight evolution and perceptions of adults living with HIV following initiation of antiretroviral therapy in a South African urban setting South African Medical Journal 101(9): 645-650
Coetzee, B.; Kagee, A.; Vermeulen, N. 2011: Structural barriers to adherence to antiretroviral therapy in a resource-constrained setting: the perspectives of health care providers Aids Care 23(2): 146-151
Hussain, A.Raza.; Abbas, S.Muslim.; Uzma, Q.; Reza, T.Ezra. 2013: Patient's perception, compliance to treatment and health education of antiretroviral therapy among HIV patients at a tertiary healthcare setting JPMA. Journal of the Pakistan Medical Association 63(7): 846-849
Kitkungvan, D.; Apisarnthanarak, A.; Laowansiri, P.; Mundy, L.M. 2008: Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense HIV Medicine 9(8): 636-641